Novartis Proposes Two-Phase Drug Development Model, Staged Approval
Executive Summary
Novartis is advocating a two-phase drug development paradigm based on "models of disease.
You may also be interested in...
Novartis, Abbott New R&D Models Focus On Translational Medicine
Translational medicine will assist companies with targeting the right indication for a compound, a Novartis representative said at IBC's Drug Discovery Technology & Development conference Aug. 8 in Boston
Novartis, Abbott New R&D Models Focus On Translational Medicine
Translational medicine will assist companies with targeting the right indication for a compound, a Novartis representative said at IBC's Drug Discovery Technology & Development conference Aug. 8 in Boston
Novartis Pursues Internal Development While Seeking External Opportunities
Novartis is using a combination of its own internal development, in-licensing deal and acquisitions to bolster its pipeline. Novartis Head of Pharma Development James Shannon recently spoke with "The Pink Sheet" DAILY to discuss the company's development priorities.